Stocks To Buy Now

Blog, Inc. (CIIX) Aiming to Grow Direct-to-Consumer e-Commerce Business

  • Company engages Launch Haus LLC, a digital agency, to grow its direct-to-consumer e-commerce business through a new marketing campaign
  • Consilium Global Research ( projects a CAGR of nearly 100% for CIIX through FY2020, with revenues reaching $14.8 million
  • CIIX has goal of becoming the largest Chinese publicly traded company in the legalized cannabidiol (CBD) market, with a target audience of the global Chinese-speaking community, Inc.’s (OTCQB: CIIX) goal of growing its global sales of hemp-based cannabidiol (CBD) products will be aided by its engagement of Launch Haus LLC, a Scottsdale, Arizona-based holding company specializing in digital direct-to-consumer marketing and product branding.

CIIX has a goal of becoming the primary Chinese medical cannabis publicly traded company. It is focused on the research and development and distribution of legalized CBD to the global Chinese-speaking community. It has an online store in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar store in its home market of San Gabriel, California. Sales of CBD are legal in China, while marijuana is not.

In a recent update, ( noted, “Launch Haus has been engaged to develop a customized cutting-edge direct response marketing campaign that will focus on personalized, customer-centric marketing and sales force automation; develop a compensation plan that incentivizes both rapid growth through recruitment of new, entry-level consumers and top-tier distributors; introduce CIIX to its stable of industry-leading suppliers for global payment systems and logistics and its network of distributor recruitment and legal governance and compliance professionals.”

The report added that the principals of Launch Haus have a proven track record of building sales organizations and developing go-to-market planning and customer experience consulting. CIIX, it notes, believes it is on track to announce an official launch date of its direct selling platform in the coming fiscal year.

Consilium Global Research projects that CIIX will achieve sales of $14.8 million by FY2020, outpacing the growth of the CBD market with a compound annual growth rate (CAGR) of nearly 100% in that time period.

Let us hear your thoughts:, Inc. Message Board

Latest From Twitter

Follow us: @Buy_Stocks_Now

From Our Blog

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

September 18, 2017

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the […]

Rotate your device 90° to view site.